REGISTERED CHARITY NUMBER: 290959
REPORT OF THE TRusfEES AND
iJNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
FOR
BRITISH GYNAECOIA)GICAL CANCER SOCIETY

BRrrIsH GYNAECOLOGICAL CANCER SOCIETY
coiYrEiYfs OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
P88e
Report ofthe Trn$te¢s
I to 7
ltt¢tep¢nd¢nt ExiThln¢r's Report
S¢*¢¢meDt of Fin*nti#l A¢tlvltl
BAlante Sheet
io
Cash Flow Sta¢eme￿I
Notej to tbe C￿h Flow StstemeDI
12
to the FinaneiAI Ststements
13 to 19

BR￿lSH GYNAECOLOGICAL CANCER SOCIETY
REPORT OF THE TRUSTEES
FOR THE YEAR Ef4DED JI DECEMBER 2025
The Irustees pr¢$¢nl their report with thr f]llaDrial st￿tt￿ent% of Ihc charity for the year ended 31 DcceJnbBr 2025. The
stees have adopted the provisioDS of Accounting and Reporting by Charities.. Ststemcnt of RccoTllmended Pra¢ti¢e
applicable to chariiics preparing their accounts in ￿cOrdan¢e witb the Fina￿la1 keporting Standard applicable in the
UK and Republic of Ireland (FRS 102) Icffe¢tive l JaThu￿ 2019).
OBJECTIVES AND ACTIVITJFS
Objeetlves and alms
The objects of the charity are lo advunrE the s¢i¢nc¢ and art of gYj￿0]08lC8l oncology for tIK beJ]¢fLt of the public.
The Brilish G￿ae(oloBlCaj CgJJG¢T Society {BGCSI se¢ks to acthieve these objectives by..
- MakiThg grant5 to individuals aTKi supptirting rese8rth in 8ynaecolo8ical ottcology.
- Sponsorin8 and un(krtaking r¢sear¢h relcvanl to th¢ prevention. dia8rK>sis and treathjrnt of gynae¢ologt¢81 c8wers.
- ProvidiDg advocacy. prOt￿lOnal advice and information.
- RuJ]niDg con5en5U5 pior¢ss¢s and me¢lin¥s on important a￿a5 of gyna¢cological caTK¢rra￿,
- Developing and publishi08 clini¢al guidelines for the dLBgIK)5is arKi managemeht of g>￿&t￿l0￿c￿ ¢an¢¢rs.
- Working with the Royal Coll¢g¢ of Ob5tsrrieian5 and G)maecologists (RCOG) and Nh¢T prof¢wional organisations to
support d¢velopmentof tr4inin8 ¢uryi¢ula and surgical skills.
Supporting ihe professional development of members 8T￿ th¢ WKler mullidiscipliDary W0￿roT¢¢ involved ID
gynaecological cancerc4re.
- Aciing as an w)Jbrelia and rtsource body for prof¢ssiOt*ls involved in gyrw¢wlogi¢al oncology.
- Supportin8 an annual scieDtific meetiDg ¥ddr¢ssing impoMI d¢v¢lopments in gynaecological o￿￿10gy.
- Awardin8 prizes for hi8hsuality SCLelJtkfK work pr¢s¢nted at the Annual Scientific Meeting.
- Supportin8 trainees ar￿ subspeciality fellows through cdvcational aclivitie& r¢scoTch 8r&nts aThJ otheroppornnitie&
blk b¢nefrt
The trustees confirm that t￿Y hav¢ tvf¢tted to the 8uidance contained in the Charity Commission's suidat￿t on
public benefit wheTh revi￿￿7￿8 the ChRriW5 aims and (pbj¢¢tiv¢s aml in plan￿n8 fL]b]re activities.
The trustce5 C0115ider thAt the Srtietys a¢tivit1¢5 provide publtc bcncfii by promoiing edu¢ation, r¢sear¢h, profts8ional
developn]¢nt Ènd improvements irt the quHlity of care pl0vid￿ to PEDple affetled ty gynaecological Cancers.
P4ge I

BRITISH GYNAECOLOCICAL CANCER SOCIETY
REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31 DECKMBER 2025
ACHIEVEMENTS AND PERFORMANCE
Tbe BGCS continued to develop and exp&￿1 during 2025. reflectin8 the inw¢asingbr¢•dth of the SDciety8 activiti¢s 8nd
its membership across the multidis¢ipliThary PTvfcs5ion8 involved in 8ynattolo8i¢al canrwrare.
Tbe prirKip81 aijrs of the BGCS remain to a¢fvo¢ate for hi8h-quality &ynae¢ological catw seNAces, pmmote education
and rese￿h. support the h¢8lth¢ate PT0fe$5i￿a]s involved ID deliverin8 Ih¢se service& and ellcoura8e best practice in
the diagnosls. tream?enl and care ofpeople affected by gynae¢ologieal canrxr.
Annu81 &l¢mtir￿ MeftSng
Th¢ 2025 BGCS AEJnual Scientific Meeting w held in London aTKI a succe&rful sci¢ntifi¢ and thational mectin
li attract¢d 565 d¢legat¢s, with pr¢sentstions from national and itbt¢rn81ional spe&k¢rs coveriftg a broad Tang¢ of
developTtaents in 8yDaecolo8ical cancer.
Tbe meeling rcturned a small fjnattial sllrplus.
The Briti5b A55ociation of Gym2ccological Patholowsts (BAGP) held a parallcl mceting alongside th¢ BGCS Antwal
Scientific Meeling. This further Stren￿￿£￿￿ Jlliunc¢ bctween the two organisalions a￿1 eTrcourag¢d closcr
multidisciplinary roll3boTrtion between g￿LaeCo10gic￿l onwlogists and Sp￿la11$t gynaecological pathologists.
The oext BGCS Annual Scientific Meetlll8 is planned to tsk¢ place in Bristol in Jwi¢ 2026.
Trglnees and mbspeclllty fEIIows
Supporting the next generntion of gynaecologirdl o￿OI0￿1$1S remains & majorpriwity for Society.
The BGCS held a surc¢ssful rneeting ill January 2025 6pecifi¢4lly fot ¢rain¢e5 and gynaecological oneolo8y subspecialty
fellows. The m¢eting provided edu¢atio#al. professional developrt￿llt and networkiilg opportunities and enabled tyginees
ty diSa￿S is5u¢s relevarjl to thetr training and fuwrc careers.
The Society Continues w support subbi*rialty fellows and nuintaiThs ¢los¢ links with the Royal College of Obstetricians
and Girywcologi5t5 in ￿lation ¢0 sub5p¢cialty training.
The BGCS is Cot￿¢10￿ that the￿ are CUryEntly a signifjcant llum￿r of Consultant vacancie5 wiihin UK gymae￿IQBl¢8l
oncology services and that appropriate workforcc plaDnin8 and the tt8inin¥ of suffirient nufflber5 of future consultants
important to mainrainin8 high-quality gynaecological cancer services. The BGCS Sub$￿101ty 8roup therefore
continues to liaise ¢lo$¢ly ￿7th th¢ RCOG to assist with dccision-njaking and workfor¢¢ planning in this area.
Vnlt gynaetoloiists
The Society held a SUCCL8RfiJl ftwing in Bimiingham for Unit Gynaecologists with a Special Interest in Gymaecological
Cancer.
Supportins clinician$ workin8 io ¢anc¢r uniis 1ernain5 an part of the Swietys work. These medings facilit8
ucation, comrnunscation belwEen can¢eT Unlts and ¢anr¢r centre5. disscminatioTh of best pra¢ti¢e and discussion of the
pArticular dwll¢n8es faced by clinicians mmawng patients with 8yrAttotogi￿l utK¢routside specialist cancer centres.
Rese#rch grants
The BGCS continues lo provide rjA￿￿111 supw¥rt for gYna￿OI081Cal CaDcer research and to en¢owoB¢ research activity
amoTLg5t trainee8 and other member5 of the Swiety.
During the year. the Society offered research gratrts ¢0 trainees and other eli8ible appli￿n¢$. These included grants
administered ditectly by the BGCS as well as ¢0118borntive grw)Is with Wellbein8 of Women.
Applications for BGCS rts¢aroh 5UPPOrt conlinue lo dett)DtJsirnte the importance of providio8 QPPOrtunities for traiTJ¢es
and other ffseaTrher5 to develop re￿reh projects in 8YThae¢ologi￿7 cancer.
Collibor*tion with gyMec4)IoElcg1 tancer ch8rltles
The BGCS continues to work ¢loyely with ¢h8rities rep￿Senting and supporting p￿pIe affected by 8yIKeeolo8ical
cancers.
Regular rncctin85 llTe held wth other 8)ryv¢oIo8ical ￿t￿er cknritie5 to ensure that imp)rtant issues aff￿11￿8 Patients
Dd gjnaecological caT￿tr 8eTvices C￿ wh¢T¢ appropriate, be addressed nationally in a coordinated and eohesivc
manner.
Owdnisation$ participating in these di8cyssh)ns have I￿l￿ded W¢Jlbeing of Women, The Eve App¢AI, Pehches Womb
Cancer Trust. Target Ovarian CanLrr, Ov8come and Ovarian Cancer Action.
Th¢s¢ ¥¢l&tionships provide #n important mecbanism for ensuring that tlle PTofe&sional rtr4Jectivt of the BGCS
inforn]ed by the exp¢ri¢nce5 and prioritics of patients atNI the organisations representing thenL
aini¢al guideli1￿ and c¢)nsellsus development
Page 2

BRrrisH CYNAECOLOGICAL CANCER SOCIETY
REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2025
The BGCS Guidelines Group coMinu¢d its work during 2025 on the development and revision of clinical guidelines.
including the Swiety'¥ Lmical ¢JJJ¢¢r¥uideliThes.
The d¢v¢loptn¢nt of ¢vid¢nc¢-based 8uideliThe5 remain5 a core activity of the Society aTKi suNN)its th¢ BGCS objective
ofpromoting ¢on*s*n¢ high4wality care for patients with gY￿e¢O]0g1Ca] CAncer ihroughoul the UK.
The Society also initiated a Delphi con5ensu5 pr(￿55 COllC¢tniug th¢ introdu¢iion And use of hyperthem)i¢
i￿￿peri1￿ntg1 ¢heny)therapy IHIPECI ill OV￿1a￿ can¢et.
The pwpose of thi5 pmcess is to establish expcrt cotbS¢nSUS ¢on¢¢min8 the appropriate introduction and delivery of
HIPEC 8nd to pn)vide 8uidance for clinLCl8f15 a￿j 5erYi¢¢$ con$id¢rin¥ its impltmentaiion. The Society anti¢ipat¢s t￿t
the r¢Suliingcons¢ns￿ statement will be cotnpletd 8tyJ am)ouDced durin8 2020.
Syrglcgl Sk1115 Projeet
Durin8 the year. BGCS ro113borkted with the Royal Colle8e of Obsletriciarfj and Gynactologists and other relevant
profc55ional 5(KiCties on a Surgi￿1 Skills Projert.
The project seeks to identify the surgirni s*il]s and trdiDing requiren￿nts that will be n¢¢¢ssary for fvture generitioTh¥ of
gynaecological surg¢on5 to ¢onsid¢r how appropriaie SUTgical training ¢ath be d¢liveTed in the context of changing
clinical pra¢ii¢e, technology and W0￿f0rcC requirements.
The BGCS considers maintenance atKi developtncnt of high-qu￿tty surgical hining to be fuTrJ&rncntal to the bjture
provision of safe and etTective 8yJaecoloÈical ¢an¢¢r sutg¢ry will conlimje to contnljute to this work.
E•dometrlal ¢8Tr¢er •udlt
The national endometrial cancer audit, u[￿ertaken in collaboratiott with the National Di5e8se Registration SeJvi¢e
INDRSINCRASI, Peaches Womb C￿n￿r Tritst, The Eve Appeal at￿ the British As80ciation of Gyna¢wlo8ical
Patholo8LSts. publishcd the first rerA)rt.
Th¢ a￿li1 represents an ifflportani pi¢¢¢ of work ¢XarniTUTh¥ Ihe manJ￿rnent of endomeliial Fancer and provides
inforn?ation that can be used tQ uT￿etstand variation in practice and identify opp)rwnities to improve the quality and
con5jStency of car¢.
Following the s￿¢¢¢5$fvl ¢ompl¢tion of this worK th¢ BGCS is seeking fwmling to und¢n4k¢ a similar natiDTMI audit of
vu]val canr¢r.
Internat10￿81 Gyn8etologieal C•n¢tr So¢iely
The BGCS has maitttained a relationship with the Iniernaiional GyMe¢olo8ical Cancer Society (Ica), following
Strategic alliar￿e e5tBblish¢d PTtviously.
In light of the developjnetrt of Ihe BGCS and ihe ¢han¥ing r¢quirem¢nt$ of lis n￿￿be￿ipl the Swi¢ty has decided to
review sts relationship with th¢ IGCS. This review will con5id¢r the bencfits Provided to BGCS m¢n*ew& opportunitie5
for international education and Collaborntion, and whether the current arTangeinetts COniinu¢ to repfesent an appropriatc
of the Societys resourL%
Any future a￿an¥ementS will b¢ d¢t¢rmined followingcompletion of thi5 review.
FINANCIAL REVIEW
nanci*l pwlllo
The Charity incurred a net deficii over in¢om¢ of £110,721 in th¢ yrdr (2024.. 8 nct deficit of £89,376), th¢ff was 3
deficit of £97 J610Th unrestricted fijnds and a TWt deficit of £13,360 on Testricted fund5.
As at 3111212025 the unrestricted fvnds St(￿ at £435,502 12024.. £532.863) and restricted funds si(MJd at £nil (2024..
£13J601 and this included b2Trk balance5 of £421.558 12024.. £513,278).
The iTU5tee5 Co￿lJ¢r the fiDancial ￿}sitiOn of the rhwrity lo be ￿tisfaCtOry.
Page 3

BRrrisH GYNAECOLOGICAL CANCER SOCIETY
REPORTOF THE TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2025
FTNANCIAL REVIEW
Reseryes pol(cy
Thc Tr¢a5urer will monilor tbe financial resetves of the charity and is responsible for reco￿ & r¢setves polL¢y
which will be reviewed by the Trustees on an annual basis. The curreTht reserv￿ ￿lIcY wa$ agr￿￿ at th¢ cowi¢il
meetiny in JuDe 2017 and is based on the followryt)g princip&ls.'
-The BG(S should keep reserves that can the working of the charity for a year.
-Th¢ BGCS should not keep reserves ihai are excessiv¢. Assuming the Tequirement for Th*int4ining regerv¢s for on¢
year is ¢he Gharity should avoid k¢epin8 reserves ￿ater than 80% of the stmi of ihe annual in¢ome a]Ml ¢xpenditwe
av¢raged over five yel
-Wh¢n JYs¢rvts are excessive. the chBrity shou]d explore new avenues of ¢hrritablE activity.
Under th¢ curtEni res¢)w¢s poli¢y resaves ai the ye4r ¢Dd c¢)ntinue to b¢ hith d¢spi* p1W￿EdexrR[YJiIllre on funding th¢
feasibility pilor of 2 National ErtdometriAI Cancer Audit Pilot (ECAPI. fu]thtr expcnditurt on the Webinar educalionai
programm¢, fimding of 2 ¢ons¢nsus meetittg5 and funding of an additional sub-group. In 2020 Council &y¢ed
additional spetmling to wpw)rt Traine¢wTrdiners Annual Sunllnii discount¢d Jrgistration fees to suppori nurse
members attending Annuol Scientific Meeiing, increased expeThditur¢ on PTiZ¢S. owards, ￿¥¢1 fellowsthips aThl
researchlaudtt grants.
FUTURE PLANS
During 2026. the BGCS irtends to COAlinwe and develop its adivities, including:
- HoldiD8 th¢ Annu#] ScieMifi¢ M¢eting sn Btislol ID June 2026.
- Electing the s￿Iety's first Vice Presid¢nt utmler the revised governance structure.
- Continuing development of thc c¢rvi¢al ¢atKerguidelines.
Cvmplcling the Delphi conwh5us process relating to HtPEC in ovarian canccr. wryth the intenlion of publishing or
announcing the eoThsensus sta*meni before the end of 2026.
ContimiiDg to 5UPWt trainecs and 5ubspxi&lty fellows and contsibuting to diseussiofL5 r¢gardin8 the
8yD8ecological oncolo8y workforce.
- Continuing roll3bortion with the RCOG and oiher societies ort the Surgiul Skills Proje£t.
- Continuing Tcsearch grant prOgranU￿￿. i￿luding ¢ollaborntiv¢ fimdthg with Wellbeing of Women.
- Reviewing th¢ Soriety's relationship wiib the lThlernational G￿)1¢¢0]081¢Jj ca￿¢[ Society.
- Continuing ￿gular engagenientwith national 8ynattologi¢al tsnr¢r thaTitifS.
- Seeking fimding forthe development of a national vylvsl c8D¢¢r audit.
- Continuing to d¢v¢lop the BGCS'S role in promot?n8 hiBWualtty. evidenctrbased and equitabl¢ 8yM¢wlogical ¢anc
CaTe throughout th¢ Unii¢d Kingdom.
- EsthblishmEnt of annual Fnuliidisciplinary Vulva s￿O51w)L
The InJsl¢¢s consider thgt the* a¢livilirs will fiJrtTr￿r thc charitable objectives of th¢ BGCS and cnbance the Society,
ntribution to impTowng oth¢omes atld care for P￿pIe affe¢td by gyJw¢ologt¢al cancer.
STRUCTURE GOVER14ANCE AND MANACEMENT
Goverulng d•tuthent
The ¢hgrity is Controlled by its governing document. a deed of tru5¢ and ¢onstitytes an unincortM)fdtcd charity. The
British Gyn8#olowcal Cancer Society i5 con51Ltuted und¢r a deed odopied Ai the time of thE inaugural m¢eting on the
6th October 1984 and amendd on th¢ 6th May 1988. 30th April 1994. 20th May 2004 atwj 21 JurK 2013. It is
re8lStered charity, numb¢r 290959.
Page 4

BIUTISH GYNAECOLOGICAL CANCER SOCIETY
REPORT OF THETRUSTEES
FOR THE YE4R ENDED 31 DECEMBER 2025
STRUCTUR4 GOVERNANCE AND MANAGEMEr
Ckarlty ¢ons¢ltutlon
Tbe rnng¢ and volume of activities undertakets by th¢ BGCS have increased con5idcrably iaj r¢G¢nt years. These inct￿le
¢du¢atiothal meetin85. 8ULdeline d¢￿]￿p[￿¢￿1, rwrch 8rants. national audils. cngagement wilh patient charilie
workforee issues. profe55ional advo¢aey artd ¢ollabor8tioD with other national and international org8r￿$￿tI0￿s.
InTeco￿lt10n of this increased worklo&d, the Society agreed a rcsolution to )mend its ¢onstitutioTh so that the BGCS will
F¢nron¢ntly have fourOffi¢ers raib¢rthan three.
The additional Officer will hold th¢posiiioTh of Vice Pre5id¢nt atNi will also s¢rv¢ as an additionAI tr￿tte of the So¢i¢ty.
The pu0￿S¢ of this ¢hang¢ is to illcrease the leadership and govenwi¢e capacity of the Society and to di51nThu* the
increasing workload ￿n￿ngSt 8 largcr Officergroup.
The first Vi¢¢ President under thc new aTrangeTJftts is due to be elected in JurK 2026. The suc¢essfvl ¢wJdidate will
5¢TV¢ for two years as Vice Prcsideth followed by a fillth¢r hvtryearterni as Pre5ideni.
Th¢ trustees b¢li¢ve that this ehange will stretigth¢n coniinuity of leaderships suc¢ession plat)niJ]8 4nd governanLe witbin
the BGCS wthile providing additional capA¢iry to supp)rt ihe expanding adivit1¢5 of th¢ Society.
RecndtrneDt xppointment of ttew trngtees
The olfice holder5 of the Society (P￿sIdent. Hon S¢¢retary 8nd Hon Treosur¢r) have 8Utomaiically held the role of
Trustce since the inception of the Society in 1984. It wa5 decided tsi ai th¢ sumtrw council me¢ling of Ihe soriety on
8¢h July 2015 that th¢ ￿ciety should formaliBe the appointTnenl of non£xe¢uuve trustees aTML thi5 wa5 ralifi¢d at the
AGM of l(hh July 2015. It wa5 decided that tTr￿ offica¥ of the cowieil as described in the eonthwtion of the BGCS
2015 Section131 would be Join￿ in the role of tru5ters by no less thwj ¢wo 8nd no more than four non-volin¥ trustees to
s¢tv¢ for threc ye4r8. The aim of council to seek applications fTOTn the t1￿￿¢ ￿￿￿1¢n¢¢4 I￿lIvidual$ witkn'n the
rnernb¢t5hip and ir wa5 ¢nvisaged that such Candidates would be either nearing th¢ cnd of or hav¢ r¢tiTd ftorn clinkcal
a¢tic¢. The memkr5hip was a5k¢d to self nominare for the position or nominate a colleague if Ihcy were agtyttable to
taking up the rA)5ilion. by OctobEr 315t 2015. Subsequently two individua15 were identified who w¢re approached and
who both accept￿ the position of truslee. TheLT appDintm¢nt was ratified at AGM of 15th May 2016. The n¢wly
appoinwl m]st¢es 5Ent invitsiion l¢tt¢T whi¢h directed thellL ￿ background reading regarding their 5ta¢ulory and
Socsety responsibiliii¢s. Both trustees accepted by rrturn of posl. The fjrst responsibility delegated to the two n¢wly
appointed tW5tce5 Was the recruitment of a third Tlon voting Ir￿1¢¢. id¢t)tifi&l at the council [r￿Cting of 9ih Febnmry
2017 8nd subsequently directlyapproachtd wih ihe ￿rne invitation Ictter used pr¢viowly. The third noD.voting trustee
accq)ted the posiiion fornmlly on 13th March 2017 aTwJ ihis 8ppointm¢llt wTrs ratified at the AGM on 15th June 2017,
thi$ p¢rson has now stepped down from th¢ tsvsree position for PCT50Dal r¢Rsons at the end of 2020. A new IT￿￿￿¢c with a
JKpn mdi¢al background and experti% in l¢gal affairs has sitte been appointed.
The current constit￿lOn(20l7I states in relation to truslee&-
Section 2 (Membership of the Society)
Trustees
I. TNsÈees are r¢quir¢d by the Charity Commission.
l Tnjstces shall be r¢eomm¢nded by Council and ralified by the AGM.
3. Twst¢¢S shall Serve a miniiniim i¢mi of three years and thi5 ierm may b¢ re[￿ble for up ￿ two further tenJLs.
certain CiTEwn5tan¢es th¢ terni may be extenthd by E further one year to allow for overlap and ensuring Suitsble
candidates are in post to provid¢ cojjtinuity to the Society.
4. There $h811 be a minimum of 2 and a maximum of 4 tNst¢¢s will r￿1 have voting rights.
5. Trust￿5 shHII b¢ individuals WI￿se qualificJ¢ioD$ and ]￿livatIon would be of value to th¢ BGCS in P￿rn01]ng its
goals within the rnks of its charitsble siatus.
Rlsk man8geme
Th¢ trustees have a duty to id¢niify and review Ih¢ risks to which the Clwity is exposed aDd lo ertsure appropriat¢
contro15 are in place ¢0 provide ffasonable assuTance against fraud and error.
Pagc 5

BRITISH GYI¥AECOLOGJCAL CANCER SOCIETY
REPORT OF THE TRUSTEES
FOR THE YEAR E￿,DED 31 DECEMBER 2025
STRucfuRE GOVERNANCE AND MANAGEMEf4T
Overnjl Performinte
Overall, the trustees consider that the BGCS continued to a¢hi¢ve its rharitable objcctiyes successfillly during 2025.
The Society r¢tnaiTr5 8 thriving multidisciplinary or8anisation with art expanding role in education, reseaff]4 guideline
deve]opm¥Dt, c]ini¢al audiL profe55ional trdioing. work(¢)rc¢ planning aThl Ad¥oca¢y for hi8h4wality 8yJ¥8ecologi¢#l
cancer C￿%.
Th¢ suc¢essfvl Annual Seientsfic Me¢tin& dcdicated meetings for trainees and Unit 6￿a¢COlo¥i5ts, cijntinued reSea￿h
fundin8. publi¢&tion of the MtionAI endometrial Cal￿er audit. developm¢ni of clinscal guidcline5 and CO￿￿¢￿%￿8 wor(
and intreatsing ¢ollaboTrtion with prof¢5sional b￿leS and patient ¢haTities demJ]strate the breadth of the &xiety'8
Sctivities.
The tnjstees reco8nis¢ that th¢ increasing ￿CtivItIeS of the Society also create additionAI govern#￿e and athninistr4tive
responsibilities. Th¢ ¢onstityiional ¢hAnges ¥￿ted during the ye4T arc intsndd to that Ihe Society has atL
appropria*1¢4dership SIn￿lUre to support ihi5 gTOWIh.
The BGCS will ¢ontit)u¢ io work Nryth its mell]be￿ the Royal College of Obs￿￿1¢1&￿$ atyj GY￿¢0]0￿15t￿ other
Or￿lOnal societies, patient thatxties al￿ national oYganis*tK)n$ to improve th¢ diagnosis tr￿tMent and Caye of people
affeetrd by gynaecologjcal cancer.
REFERENCE Af4D ADMtNISTRATIVE DETAILS
Reglstered Ch8rlty ThurA￿r
290959
Prlntlphl Addre
GI￿}
Ffordd Y Parc
Parc Mcnai
BangoT
Gw)Tredd
LL57 4FE
Trust￿8
Mr S C Lee50TL{apwinicd 29.126)
MF C Cban Iresi¥ned l.1.261
Proft550r J Shepherd (resi￿d l.1.26)
M$BRai
MT S Dobbs (resigned 10.7.25)
Mr A J Phillips- (Secreiary)
Mr K B GO￿ar (resigned 10.7.25}
Drw D G Rathavelu- {Tr￿￿re[l (&pp)in*d I1.7.25)
T E J Ind - (President) (appoint¢d 10.7.25)
Prof M Wells {appointed 29.1.261
Dr N J Wood (appointed 24.6.20
Ind¢pendent EJimlTher
Colin Bell FCCA
Williams Denion Cyf
Chart¢red C¢rtified Acco￿*￿￿
Glasly
Ffordd y Par¢
Parc M¢rni
Ban￿r
Gwynedd
LL57 4FE
Page 6

BRITISH GVNAECOLOGICAL CANCER SOCIETY
REPORT OF THE TRUSTEFS
FOR THE YEAR ENDED 31 DECEMBER 2025
Approved byor<krof the iN)ard of In￿te¢S on 29 S¢ptrmber 2026 8T￿ $i8ffd on its beh*lf by:
T E J Ind- TnL8tee
Pa8e 7

INDEPENDEPn EXAMINER'S REPORT TO THE TRUSTEES OF
BRITISH GYNAECOLOGICAL CAf4CER SOCIETY
Independent examlner'j T¢￿rt to th¢ tru$ltts of Brfttsh Gymaeeologieal Cancer Sockty
I report ￿ the charity tr￿t¢e$ on my examitt81ion of the accounts ofBrilj5h G>ma¢cological C4tw Soci¢ty (the Trust)
for the year ¢nd¢d 31 D¢c¢TDb¢r 2025.
Responsibilities basi¥ of r¢port
the charity trustees of tbe Tr￿81 YOU Are responsible for the preparntion of the a¢xounts in ac¢ordan¢e with the
requirements of th¢ Chariii¢s A¢t2011 {)h¢ A¢fj.
I report in reyct of my ¢xamination of th¢ Tnjsi's a¢¢OUntsca￿1¢d uT¥Jer Section 145 of the Act and in carrying oul
my examination I have followcd 8ll a￿lICable Directions given by the Cthttrity Cornmis5ion under s￿tion 145{5Xb) of
tho ACL
Independent ¢xamlD¢r's $t8tement
Since your ¢harity'8 ¥ross 1￿com¢ exceeded £250,0(￿ your cxllrniner must b2 a m¢mber of o lis*d b(dy. I confi
that 18m qu81ifi¢d to undertak¢ the examination ixcaus¢ l aTh a w￿rnber of the Aswiation of Ch8rtered Certified
Accountants, which is one of the l&¥l¢d IK)diE5.
I have completed my examination. I conflmi that no m&i¢ria] matters hfft come to rny attention in Conneciion with the
examination gtving me caw8e io b¢li¢v¢ thai in ony material rw¢ct.'
aecouniing records were t￿t kept in respttt of Tntst as required by Section 130 of the Act; or
the accounts do ￿t accord with those records. or
the accounts do Thol comply with the applicabl¢ requirenMi$ con¢¢miftg th¢ forni atMI content of accounts set out
in thc Charities (Accounts and Re[￿5) Re8ulation$ 2008 other than any requirement that the accounts 8iv¢ a
true arKI fair view wljich is not a matter ¢oThsid¢r&l as parrof an inde￿1 examination.
I have concerns and have eon% across w thher rnatt¢Tr in ¢onne¢tion with the exaTnination to which attention should
be drawm in this report in order to enable a prnper und¢rstsJMling of the accounts to be r¢a¢hd.
Colin Bell FCCA
Williams De¢)ton Cyf
Chartered Certified Accountsnts
Glaslyn
Ffordd y Pa
Pa￿ Metsai
B81J￿0[
LL57 4FE
Pag¢ 8

BRITISH GYNAECOLOGICAL CANCER SOCIETY
STATEME￿ OF FINANCIAL ACTivrriF3
FOR THE YEAR ENDED 31 DECEMBER 2025
2025
Tolxl
fund5
2024
Total
funds
Unrestricl¢d
Restricted
Notes
INCOME AND ENTK)WME]YIS FROM
Charlt*bh #cllvltles
To advan¢e ihe sci¢n¢¢ and art of 8yDattolo8ical
onGology for th¢ ben¢fit of th¢ public
499J08
27JOO
527,008
403,115
Investment In￿Me
655
6,655
9,738
T•tAI
511fj163
27JIM)
533,663
412,853
EXPENDITURE ON
Ch8rlt8ble 8¢tivltle5
To advance the 8ci¢nr¢ a￿A art of gyllae¢olo8i¢81
oncolo8y for the b¢nefrt of the publi¢
57&804
05A20
644J84
5¢)2,229
NET INCOMEI(EXPENDATURE)
Tr4nsfers behyeen funds
(72,701)
(24.660)
(38,020)
24.660
(11ffj721)
{89,376}
Net m•vemeDt in
{97J61)
(13J60)
(IlQ721
{89,376)
RECONCILIATION OF FUNDS
Total fijnds brought forward
$32,863
13J611
5ffj223
635.599
TOTAL FUNDS CARRIED FORWARD
435,%2
435J02
546.223
cor4TINUING OPERATIONS
All income and ¢xpendiiure has arisen from ¢oniinuing 2Ktivities'.
The n(rt¢5 fo￿ part of these fLI]ancLlll statemts
Page 9

BRrrisH GTrTIAECOLOGJCAL CANCER SOCIETY
BALANCE SHEET
31 DECEMBER 2025
2025
Tot41
fundi
2024
Total
fi]nd8
Unr¢stTiGted Restritt¢d
Not&8
CURRENT ASSETS
Dcbiors
Cash at bank
129,963
421.558
129,963
421 J58
123.959
515.278
551521
551 J21
639,237
CREDITORS
An￿￿￿1$ falling within onc ycar
10
{IIA019)
(114019)
(93.014)
NET CURRENT ASSETS
435502
43S502
546,223
TOTAL ASSETS LFSS CURRENT
LIABILITIES
435J02
435.sin
546223
NET ASSETS
435502
43S502
546223
FUNDS
Unre$tri¢t¢d fuAIs
RestrictEd fv[￿S
435A•2
532,863
13,360
TOTAL FUNDS
435,S•2
$46223
The fina￿181 statcrncnts w¢rt approved by the B(Ard of TrusteE5 aDd authori8ed foT Is￿e on 29 S¢pi¢rnber 2026 and
were SI￿¢4 on its behalf by:
TEJInd-T￿SIrt
The notes fonn part of these finHn¢ial statement8
Page 10

BRITISH GYNAECOLIKICAL CANCER SOCIETY
CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025
2025
2024
Notes
Casb nows from uper¥dTrg 4etlvlties
Cash generdted from operations
(IOOJ75)
{41,303)
N¢t used in QP¢Tatins activitie5
(IOOJ7S)
(41,303)
C8$b Ilows from Inve5dng 4ctlwitie5
IDlertsl rtteived
655
9.738
Net cash provided by ijjvthing a¢iivities
6,655
9.738
Chlnge In ¢osh and (ash EqwIv8l¢nts I
the ￿pOrtIng pcrSod
Cash and ¢ash equiv•leDts *t the
beginnitsR of the rey)rtlng period
(93.720)
{31,565)
5JS278
546,843
Cd5h gNd cash equlv*lENts a¢ the end or
th¢ reporting perlod
421558
515278
Th¢ fomipart of these financial statements
PJ8ell

RRJTISH CYNAECOLOGICAL CANCER SOCIETY
NOTES TO THE CASH FU)W STATEMEPIT
FOR THE YEAR ENDED 31 DECEMBER 2L)IS
RECONCILIATION OF NET EXPENDITURE TO Nrf CASH FEA)W FROM OPERATING
ACTIVITIES
2025
2024
Net ¢yp¢ndlture for tht r4￿rtIng period (aj per tbe thtement of
FffiDAncial Actlvllks
Adjustments for:
Interest ￿e1Ve￿
I￿re45¢ in debtors
Inc]Yase in ¢reditOTS
(1111,721)
{89,376}
{fj.659
(0,003}
23,11114
19,738)
(29.365)
87.176
Net e*5h used AD •p¢r8¢lons
IIOilJ75)
(41.303)
ANALYSIS OF CHANGES IN NET FUNDS
At 1.1.25
Cash flow
At 31.12.25
r4et casb
Cash at bat
515,278
(93,720)
421J58
515.278
(93.720>
421A58
Total
SIS278
(93,7211}
421 J58
The notes fomi part of these financial stat¢mBnts
Page 12

BRITISH CYNAECOLOGICAL CANCER SOCIETY
PIOTES TO THE FINANCIAL STATEMEIY
FOR THE YEAR ENDED 31 DECEMBER 2025
ACCOUNTING POLICIES
BA&i* of prepaTln# the statements
The financial statcm¢nts of th¢ charity. which is a public benefit enlity undcr FRS 102, have b¢en pr¢pared in
accordance MTrth the Charities SORP IFRS 1021 'Aecounting and Reporting by Ch3riti¢s.' St8tcment of
Recomrncnded PTactice applicable ￿ ch￿ltieS preparing Ihcir account5 in accvrdan¢¢ with th¢ FinaDcial
Reporting Stsndard applicable in the UK and Republic of Irelartd IFRS 1021 (effective l January 2019),,
Finan¢ial Re￿nIng Stsndard 102 The FinatKial R¢w)rting Sta]Jdard applioble in thc UK and liepublic of
Ireland, 8tyd the Charilie5 Act 2011. The flnancial statements have b¢¢n prepwr¢d under the hLStorical cost
conv¢niion.
is reco￿lS¢d when the charity has cnlltlt￿*th to tl* fmids, any performance conditions attached to
income have been m¢L it is probable that the i￿ome wll bE received aTKi the amount call b¢ n￿sUr¢dre1i0￿Iy.
Incorw from Govemmeni and other grants. Ththether 'capital' grdnts oi't¢v¢nu¢' 8Tant8 is recognised then the
charity h&8 entitl¢mcnt to the funds, any p¢rfonnance condÉtions attached to the ￿￿￿¢$ hav¢ been m¢l it is
Probable thai the inEOtne will be received and tk amount ean be reltably and is not defe￿ed.
xpendlture And Im¢ov¢r•bl¢ Y8t
Liabilities are re￿gnIsed as expenditure a5 soon as th¢r¢ is 4 l¢gal or ¢onstrnctive obli8alion LY)mtnittin¥ th¢
chatity ID ibal expenditttre. it is probable that a tT3n$fti of ee(>nomic benefits will be Tquired ID settlement and
the amount of the obli8ation can be mE&sured reliably. Expendiwre is acwNnt¢d for OTh an accrua15 basis and has
been classificd under headin85 that agwgote all cosi r¢]a¢ed io the category. Wkre wsts c#￿￿01 be dire¢dy
attribut¢d lo particular headings they have ￿en allocated to aclivitics on a basis consi51￿1 with the use of
resource5.
Itrecov¢rable VAT 1$ ¢lW as a cost in the 5tstement of financial a¢tiviiie&
Txx*tlon
The charity is exempt frorn corporation tax on its ¢h&rithble a¢tiviti¢s and is ryi5tered for VAT purposes.
Fund JlC¢OUDIIDg
Uw¢stri¢t¢d fvnds can be used in accord#T￿e wilh the charitable objectives at the discretion ofthe lThste£
Restricted futlds can only k uscd forpathculAr resrricted purtK>se5 within the objects of the Charity. Restrictions
arise whEn specified by the Itonor or when funds are raised foT Particular testri¢*d purposes.
Further ¢xplanation of the nature aDd PUfFdY5C of each fvrKi 15 irKlud¢d in th¢ notes to the financial stalcnKn
INVESINENT INCOME
2025
2024
tkp)sit a¢eount inTrresi
f4655
9,738
Page 13
continyed...

BRITISH GYNAECOLOGICAL CANCER SOCIETY
NOT&8 TO THE FINANCIAL STATEMENTS- ¢oM¢l#ued
FOR THE YEAR ENDED 31 DECEMBER 2025
INCOME FROM CHAluTAB￿ A￿1VITI￿8
2025
2024
A¢tivity
To advancc the scietxt alld art or
gy￿a￿l0&Y¢al oncology forthe b¢t)efii of
the public
Tv thE 5ci¢ncE a￿] art of
gynaeKologi¢a] oneology foT the ktlefit of
the public
To advance the 5ciuKe aThl art of
8ynaecol08i￿j oftcology for the benefit of
the pthli¢
To advance the ￿len¢e aTrJ art of
8ynattolo8ical ovoltl8y for th¢ be￿rit of
the public
To advAnce the SCie￿e aTrJ art of
gynarfojo￿¢a] oftcology for the ￿n¢fil of
the public
To advancc the Science and art of
8ynaecolo8ical oncology for the benefit of
th¢ p￿)11¢
To adv4ll¢e the science and art of
8ynaeeologi¢al on¢ology for the benefit of
the public
To advance the sciffl￿e and art of
aecological oneolo8y foT the benefit of
the pthlic
27WO
62.500
Spottsotships
IJ
833
Dele8aie fees
17J91
Subviptions
63,024
56.1)38
ASM Socia] ProgrdmTne
11th53
8,230
ASM Dele￿Tr inwne
161A39
137.110
ASM sp)n40￿1P income
24Sffj17
120363
Slmthy irtwme
150
527.01)8
403.115
GraThts receive(L in¢lud¢d in th¢ abov¢, gr¢ 95 follows:
2025
2024
Merck Sknrp & Dohme (EThlometrical Cancer Audit)
GlaxoSmithKline (EndollKtrial CancerAudit)
Eisai (EThJometrial Cancer Audit)
British A5sor. of Gynaecological PatholobTLS15 (Endornetrial can￿rA￿li1)
Ev¢ Appeal (ET￿0￿c￿l8l Cancer Audit)
Peaches Womb CancerTn]st Ilndornetrial ca￿er Audit)
30,IKrtI
20.IN)O
7.500
7.5(
27,Yl
62,500
P8g¢ 14
contLnue&..

BRITISH GYNAECOinGICAL CANCER SOCIETY
NOTES TO THE FINANCIAL STATEMEiYfs- contljued
FOR THE YEAR ENDED 31 DECEMBER 2025
CHARITABLE AcfJvJTIES COSTS
SuppDrt
Costs (
note S)
Direct
Costs
Totsls
To advance the science and ari ur
gyna¢cological o¢KoW for the benef
of the public
595,651
4&733
SUPPORT COSTS
Man8g¢n*nt
tosis
Totals
To advawe the science and art of
gjnaecological ortology forthe benefit of
th¢ publi¢
31785
11948
48,733
INDEPENDENT EXAMINER'S FEES
2025
2024
Independent examiner% fees
104$
TRUSTEES. REMUNERATION AND BENEFrrs
There no thistees. r¢r￿n¢￿tion or other IKn¢fits for lh¢ y¢8T eryled 31 Deeernber 2025 ￿)r for the year
¢Dd¢d 31 December 2024.
Tru9ttt9' expetss
2025
2024
Tn]stees' expenses
3076
5.979
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACflVTfiES
Utwtricred
nd
Restrictcd
Total
fi￿dS
INCOME AND ENDOWMENTS FROM
Cbarltable attlvil(es
To adva¢K¢ the s¢i¢n¢e and art of
gjmaecological oncology for The benefii of th¢
public
340.615
62.5(h)
403.115
Investnxnt incorne
9.738
9,738
Totsl
350.353
62,500
412,853
EXPENDITURE ON
Page IS
¢onlinued...

BRITISH CVNAECOLOGJCAL CANCER SOCIETY
NOTES TO THE FJP4ANCIAL STA TEMENTS- ¢•mtlnutd
FOR THE YEAR ENDED 31 DECEMBER 2025
COMPARATIVLS FOR THE STATEMENT OF FINANCIAL ACTivrfiES- ¢ontinued
UtYe$tricted
Restricttyj
fjjnd
Total
funds
ChiritBlJk a¢tlvl¢les
To advance th¢ %ience and ort of
naecolo8ical oncolo8y for th¢ b¢n¢fit of the
public
453,089
49,140
502229
NET INCOMEI(EXPENDITURE)
(102.736)
13,360
(89.376)
RECONCILIATION OF FUNDS
Total fvnds btought forward
635,599
635.599
TOTAL FUNDSCARRIED FORWARD
532,863
13J60
546,223
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025
2024
Othcr debtor5
VAT
98,861
67J13
5.566
51,080
31,102
129,963
123.959
111. CREDITORS: AMOUN13 FALLING DUE MryfHIN ONE YEAR
2025
2024
VAT
Other creditors
Def￿red incoTh]e
61J411
44,045
2,645
46,759
43.755
2.$00
116I19
93,014
Pag¢ 16
¢ontinlled...

BRITISH GYNAECOLOGICAL CANCER SOCIETY
NOTES TO THE FINANCIAL STATEMENtS- wlltlnyed
FOR THE YEAR ENDED 31 DECEMBER 21125
ii.
MOVEMENf IN FUI¥DS
Net
Transfers
At
31.12.25
At 1.125
in funds
funds
restfftted lind¥
General
S32J63
(72,701)
(24ffj60)
435302
Restricled f￿ndS
Endometrial CatK¢r Audii
13J6
(38,020)
24,660
TOTAL FUNDS
54A223
{110,72J}
435,502
Net nM)vement in furtds, included in th¢ above as fo]lows.'
In¢tsmin8
Resource5
Movemt
in fi]ry15
Unrestrleted funds
General fund
9)6,103
(378064)
(72.701)
Réstrleted funds
Endometrial CarKer Audit
27,$00
(65,520)
(3&0211)
TOTAL FUNDS
(644,3841
(110,721}
Ct)mp*rn¢fvu for moven*nt In fund5
Nel
nKTrv¢ment
in ￿ndS
At
31.12.24
At 1.1.24
Unrettrlcied
635J99
102,736}
532,803
R¢strict¢d funds
Endomctrial CaKYr Audii
13.360
13J60
TOTAL FUNDS
635)
(89,376)
546,223
P¥ge 17

BRITISH GYNAECOLOGICAL CANCER SOCIETY
NOTES TO THE FJIYANCIAL STATEMENTS- contthued
FOR THE YEAR ENDED 31 DECEMBER 2025
MOVEMENT IN FUNDS- tontinued
C(mparative Jkt movement in futyd5 Tr￿l￿d￿ in the above are as folloms".
InCO￿]ng
rttourees
Resources
exp¢txled
Movement
Unrestricted fund
350353
(453.089)
(102,736)
Re5trlcted fund$
EThJometrial CatKcr Audit
62J
{49,140)
13J60
TOTAL FUNDS
412.853
(502229)
(89J761
A current 12 months and prky Itar 12 ftM)nths combined wsi¢i¢)n is #s follows..
Nct
moven*ttt
in fuuds
Transfers
betwcen
At
31.12.25
A¢ l.124
UDT¢$trkted fund
635,599
(175.437)
(24.660)
435.502
Restricted fund5
Endometrial Canccr Audit
(24.6601
24.660
TOTAL FUNDS
635 J99
(200,0971
435J02
Net rnovement in f￿d$ inch￿ed in the aly)ve are a5 follow5.'
ItLCOtning
resources
Resou￿¢$
cxpended
MoY¢m¢ni
in fiuJd5
Uttre5¢ri¢ted fund
856J16
(1.031,953)
1175.437)
Regtrleied th*d$
End0￿etrIal Ca￿erAUdit
90.(KIO
(114.660)
{24.660)
TOTAL FUNDS
946316
(1,146.613)
I2¢￿.097>
PDrpose of the Restrltted FU￿￿$
Endom¢trtal C•nttr A￿lIt
The BGCS hav¢ commissioned a two year retrospecitve avdit into the IT￿]denCe. ￿A)rtality and treatment of
F￿dome[rIal ¢an¢er in the UK. The Endornetrial Cancer Audit Pmject {ECAP) has b¢cn co-funded by BGCS and
oihei chaTi¢i¢5 a5 well a5 receiving grants from som¢ pbanmceutical compfinie5.The proj¢¢i will aid the
Gwwecolo8itral Ca￿tI fDrnmunity ITh pla[￿l￿g appropriat¢ tr¢4tllKM and assess if ih¢r¢ ar¢ r¢8ional
variations in ¢he management of endojnetrial cancer within the UK
Ph8¢ 18
¢orttinucd...

BRrrisH GYNAECOLOGICAL CANCER SOCIETY
NOTES TO THE FINANCIAL STATEMENfs- eoNtl*ued
FOR THE YEAR ENDED 31 DECEMBER 2025
12.
RELATED PARTY DISCLL>SURES
Due to the nature of the charitls operdiions And composition of th¢ l)oard of knstee5 and membership both
trusttts and Tnembers will pay subscriptions and fe¢s lo th¢ Charity, other thm these no material transactions
have been identified which should be disclos¢d.
PAg¢ 19